GFH018
2 abstracts
Abstract
A phase Ib/II study of GFH018 in combination with toripalimab in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC).Org: Sun Yat-sen University Cancer Center (China), Guangzhou, No, China National Biotec Group, Shanghai East Hospital, Tongji University, Shanghai, China, Tongji University School of Medicine,
Abstract
GFH018, a small molecular inhibitor targeting TGF-βRI kinase, in patients with advanced solid tumors: final results of the phase I study.Org: Department of Medical Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China, Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China, Sixth Affiliated Hospital of Sun Yat-Sen University, Guangdong, China,